SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

An industry observers reported identification of a POET optical engine at Foxconns Hon Hai Tech Day has traders debating whether it signals renewed progress in the existing FIT collaboration. Bulls see it as third-party validation, while skeptics say a demo or ecosystem display does not confirm production shipments, purchase orders, or a new company announcement.

OFFICIAL TRUMP (TRUMP) is a cryptocurrency and operates on the Solana platform. OFFICIAL TRUMP has a current supply of 999,998,809.831273 with 281,866,746.118905 in circulation. The last known price of OFFICIAL TRUMP is 1.73532194 USD and is up 9.97 over the last 24 hours. It is currently trading on 744 active market(s) with $259,407,006.57 traded over the last 24 hours. More information can be found at https://gettrumpmemes.com/.

Trump For President

A rebound in the TRUMP meme coin has prompted speculative calls for a pump or short squeeze, while the dominant discussion remains bearish: traders call it a pump-and-dump and point to steep losses among holders. Some remain bullish or say they are accumulating, but no specific confirmed catalyst for the move is apparent.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLakes pending FDA decision on whether to accept its sonelokimab application for hidradenitis suppurativaand the review timeline, including possible priority reviewis the main focus. Traders are divided between optimism about the drug and regulatory progress and concern about approval risk, weak share performance, and the costs of commercializing without a partner or buyout.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

AXSM is drawing attention ahead of its Q3 results, with investors focused on Auvelitys growthespecially uptake for Alzheimers agitationand whether sales can support a path to profitability. The sharp share-price decline and managements limited recent commentary have intensified the debate: bulls say prescriptions may be understated by sampling and long-term-care channels, while skeptics question the pace of adoption, spending and commercial execution.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

A breakout to fresh 52-week highs ahead of expected Q3 results has put TGTX in focus, with traders watching BRIUMVIs sales momentum and guidance. Buyout and short-squeeze theories are also circulating, but remain speculation rather than confirmed catalysts.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

Regenerons strong third-quarter results, which beat expectations on growth led by Dupixent and Eylea HD, have driven a sharp share-price breakout. Traders are largely celebrating the report and bullish options activity, while some note that declining legacy Eylea sales remain a risk to watch.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

OUST is drawing attention amid a sharp, volatile pullback that traders link to weakness in growth and AI stocks, with Q3 earnings expectations adding uncertainty. The community is split between buying the dip on Ousters lidar and Physical AI opportunity and warning that shares could fall further.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovins sharp, sustained selloff is the dominant topic, with traders debating whether broader tech weakness, concerns about ad-market growth and analyst downgrades are weighing on the stock ahead of earnings. Bulls view the decline as disconnected from the companys growth and profitability, while bears worry about further downside and a weak earnings reaction.

Cava Group, Inc. is a holding company, which engages in the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. It operates through the following segments: CAVA and CAVA Foods. The CAVA segment includes the operations of all company-owned CAVA restaurants. The CAVA Foods segment includes the production of dips and spreads used in CAVA restaurants as well as sales from the consumer-packaged goods (CPG) business. The company was founded by Brett Schulman, Ike Grigoropoulus, Dimitri Moshovitis, and Theodore Xenohristos in 2010 and is headquartered in Washington, DC.

Cava Group Inc

CAVA Group Inc

CAVAs stronger-than-expected quarterly results, including solid same-store sales and guest-traffic growth, fueled a sharp rebound and revived discussion of its store-expansion runway. Bulls see continued growth potential, while skeptics point to the stocks high valuation and pressure on restaurant spending.

Arista Networks, Inc. engages in the development, marketing, and sale of cloud networking solutions. Its solutions include EOS, a set of network applications, and Gigabit Ethernet switching and routing platforms. Its product categories include core, cognitive adjacencies, and cognitive networks. The company was founded by Andreas Bechtolsheim, David Cheriton, and Kenneth Duda in November 2004 and is headquartered in Santa Clara, CA.

Arista Networks Inc

A sharp pullback after a strong run is driving discussion, with traders weighing profit-taking and broader weakness in AI-infrastructure stocks against the upcoming earnings report. Bulls see the decline as a buying opportunity given Aristas role in AI data-center networking, while others worry about further downside and whether spending expectations are too high.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Zacks Industry Outlook Highlights KDDI, Millicom International Cellular and SoftBank

Despite margin pressure and heavy network investment, KDDI, Millicom and SoftBank target growth through advanced connectivity, digital services and AI infrastructure.

3 Wireless Non-US Stocks to Watch Despite Industry Roadblocks

The fast-track 5G rollout and solid wireless traction should help the Zacks Wireless Non-US industry thrive despite short-term headwinds. KDDIY, TIGO and SFTBY are well-positioned to capitalize on the demand for seamless connectivity solutions.

Elon Musk Mocks SoftBank's Reported $100B AI Fundraising Plan: 'Only A Fool Would Give Them Money' 

Equity

Musk’s dig at SoftBank comes as the Japanese investor ramps up its AI ambitions and doubles down on OpenAI.


Stocktwits AI Roundup: OpenAI Revenue Woes Rattle Chip Stocks, SoftBank Hunts $100B, Microsoft Goes AI-First

AI stocks faced a reality check as OpenAI revenue concerns rattled chipmakers.


Quantinuum's First Earnings After its IPO: Buy or Sell QNT Stock?

Quantinuum's first post-IPO earnings could reveal commercialization progress, bookings and spending trends as investors gauge execution in quantum computing.

Zacks Industry Outlook Highlights America Movil, SK Telecom and SoftBank

America Movil, SK Telecom and SoftBank are highlighted as wireless stocks positioned to benefit from 5G, AI and connectivity demand despite industry challenges.

3 Wireless Non-US Stocks Set to Brave Potent Industry Challenges

The fast-track 5G rollout and solid wireless traction should help the Zacks Wireless Non-US industry thrive despite short-term headwinds. AMX, SKM and SFTBY are well-positioned to make the most of the demand for seamless connectivity solutions.

2 Quantum Stocks With 100%+ Upside After the Quantinuum-SoftBank Deal

Quantinuum-SoftBank's commercialization push puts D-Wave Quantum and Rigetti Computing in focus, with analyst price targets implying 100%+ upside.

Masayoshi Son Says ARM’s Valuation Could Soar Over 10X From $391B, Defends INTC Investment — ‘US Has No Choice But To Strengthen Intel’

According to The Wall Street Journal report, Son said Arm Holdings is positioned to become one of the world's most important suppliers of central processing units.

Masayoshi Son Believes Superintelligence May Arrive Sooner – Says Models Built By AI ‘Going To Be Exponentially Smarter Than All Of Us’

In a CNBC interview, Son noted that OpenAI’s next model will be built by AI itself rather than by engineers, because humans will no longer be smart enough.

SoftBank Group Corp. operates as a holding company which engages in the management of its group companies. It operates through the following segments: SoftBank Vision Fund, SoftBank, Arm, and Others. The SoftBank Vision Fund segment engages in the investment business. The SoftBank segment provides mobile communication, broadband, and telecom services in Japan. The Arm segment designs microprocessors and develops software technologies. The Others segment includes Construction and operation of solar power plants Fukuoka SoftBank Hawks related businesses. The company was founded by Masayoshi Son on September 3, 1981 and is headquartered in Tokyo, Japan.

SoftBank Group Corp. - ADR

Neutral Sentiment

<ul class="summary-bullets"><li>Musk’s xAI is positioning Grok to compete with <a class="mention" data-mention="$OPEAZZX.P" data-symbol-id="OPEAZZX.P" href="https://stocktwits.com/symbol/OPEAZZX.P" target="_blank">OpenAI</a>’s ChatGPT and Google’s Gemini.</li><li>SoftBank is reportedly in talks with Gulf investors for the new AI fund.</li><li>The Japanese investor’s costly AI bets come amid high-yield borrowing and questions about its financing strategy.</li></ul>Elon Musk has taken a swipe at SoftBank after the Japanese investment giant reportedly sought to raise as much as $100 billion from Gulf investors for a new artificial intelligence fund.&nbsp;“Only a fool would give them money,” Musk <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/elonmusk/status/2108451777406435647?s=20">wrote</a> on X in response to a post about a planned fundraise. &nbsp;<figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_10_09_at_1_54_32_PM_e96cc7cc74.png" alt="Screenshot 2026-10-09 at 1.54.32 PM.png" width="655" height="263"></figure>&nbsp;<h2 class="st-heading-2">Musk Takes Aim At SoftBank’s AI Ambitions</h2>Musk has put himself at the center of the AI race through a sprawling business empire spanning Tesla (TSLA), SpaceX, xAI and its chatbot Grok.&nbsp;His AI ambitions have also led to repeated clashes with OpenAI CEO Sam Altman, whom he has sued over the company’s shift from a nonprofit structure to a for-profit model. Musk co-founded OpenAI in 2015 but left its board in 2018.The latest jibe comes as technology companies and investors race to secure the capital, computing infrastructure and talent needed to compete in AI.&nbsp;Musk’s xAI is developing Grok to challenge OpenAI’s ChatGPT and Google’s Gemini, while his other businesses offer potential avenues to deploy AI across autonomous driving, robotics and space-based infrastructure.<h3 class="st-heading-3">SoftBank Eyes $100 Billion Gulf Fund For AI Expansion</h3>SoftBank, meanwhile, is looking to expand its already substantial exposure to the technology. According to a Financial Times report, Son has held discussions in recent weeks with senior figures in the United Arab Emirates and other Gulf investors about raising as much as $100 billion.&nbsp;The proposed fund would acquire companies and improve their operations using AI and other advanced technologies. SoftBank’s robotics and physical AI business, Roze, is expected to play a key role in the strategy.The fundraising effort would add to SoftBank’s major commitment to OpenAI. The company has committed billions of dollars to the ChatGPT maker.However, the same exposure has raised questions about its financing strategy. SoftBank raised more than $11 billion through a high-yield bond sale last month, with yields reaching 9.75%, highlighting the cost of financing its bets.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/is-i-phone-18-pro-demand-slowing-apple-reportedly-cuts-october-component-orders-stock-slips-premarket/cZD6S7ZRBVr">Is iPhone 18 Pro Demand Slowing? Apple Reportedly Cuts October Component Orders, Stock Slips Premarket</a>&nbsp;

Tesla, SpaceX and X CEO Elon Musk attends a meeting on artificial intelligence in the East Room of the White House on September 29, 2026 in Washington, DC. (Photo by Kevin Dietsch/Getty Images)

Musk’s dig at SoftBank comes as the Japanese investor ramps up its AI ambitions and doubles down on OpenAI.

Elon Musk Mocks SoftBank's Reported $100B AI Fundraising Plan: 'Only A Fool Would Give Them Money'

Alphabet Inc Class A

OpenAI

SoftBank Corp.

SpaceX

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$13.82
Prev Close	$14.94
Open	$13.81
Dividend Yield	0.18%
50-Day Moving Average	$17.81
Beta	2.23
Avg. Volume	4.04M
PE Ratio	4.88

52-Week High	$28.97
52-Week Low	$10.55
Market Capitalization	$157.52B
EPS (Annual)	$2.90
Price to Book	1.40
Revenue Per Employee	$702,420.30

Feed

News

Sentiment

Earnings

Fundamentals

Info

SFTBY Fundamentals